SCHEMBL5799296

SCHEMBL5799296

CC1(C)CC[C@]2(C(=O)O)CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)CCC(O)(O)C(C)(C)C5CC[C@]43C)[C@H]2C1

nearest known ligand 0.73

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTPN1 P18031 11/20 0.73
PTPN2 P17706 7/20 0.73
POLB P06746 3/20 0.72
F3 P13726 3/20 0.72
AKR1B10 O60218 3/20 0.72
GPBAR1 Q8TDU6 3/20 0.72
PSMB11 A5LHX3 2/20 0.72
PSMA7 O14818 2/20 0.72
PLA2G1B P04054 2/20 0.72
PTPRC P08575 2/20 0.72
PTPRF P10586 2/20 0.72
PSMB1 P20618 2/20 0.72
CES1 P23141 2/20 0.72
ACP1 P24666 2/20 0.72
PSMA1 P25786 2/20 0.72
PSMA2 P25787 2/20 0.72
PSMA3 P25788 2/20 0.72
PSMA4 P25789 2/20 0.72
PSMB8 P28062 2/20 0.72
PSMB9 P28065 2/20 0.72

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2586364 1.00 PTPN1 (0.73) PTPN1PTPN2POLBF3AKR1B10
SCHEMBL5797472 0.91 PTPN1 (0.72) PTPN1PTPN2POLBF3AKR1B10
SCHEMBL381229 0.89 PTPN1 (0.69) PTPN1PTPN2POLBF3AKR1B10
SCHEMBL2397201 0.87 PTPN1 (0.68) PTPN1PTPN2POLBF3AKR1B10
SCHEMBL23781841 0.86 USP2 (0.69) PTPN1PTPN2POLBF3AKR1B10
SCHEMBL5795816 0.86 PTPN1 (0.72) PTPN1PTPN2POLBF3AKR1B10
SCHEMBL5799434 0.86 PTPN1 (0.72) PTPN1PTPN2POLBF3AKR1B10
SCHEMBL5799378 0.86 PTPN1 (0.72) PTPN1PTPN2POLBF3AKR1B10
SCHEMBL15687736 0.86 PTPN1 (0.68) PTPN1PTPN2POLBF3AKR1B10
Gypsogenin SCHEMBL29722834 0.85 PTPN1 (0.83) PTPN1PTPN2POLBF3AKR1B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2006064583-A1 TERPENE, METHOD FOR DETERMINING ITS BLOOD CONCENTRATION, AND METHOD FOR ANALYZING ITS PHARMACOKINETICS USE-TECHNO CORPORATION (JP) 2006-06-22 WO disclosed